Alise Pa Davies
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alise Pa Davies has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Adnan T. Mbbs Bhutta
Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine/Riley Children’s Health, Indianapolis, IN
1 shared publication - Cortney B. Foster
Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland, Baltimore, MD
1 shared publication - Liliana Simon
Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland, Baltimore, MD
1 shared publication - Stephanie D. Jarrin
Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland, Baltimore, MD
1 shared publication Sun Kai
Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD
1 shared publication- Yudy Fonseca
Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland, Baltimore, MD
1 shared publication
Latest Publications
- Open Access
- 15 January 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (1) , e1206
Prevalence of Pulmonary Embolism in COVID-19 Positive Critically Ill Children
OBJECTIVES: To investigate the prevalence of pulmonary embolism (PE) in children admitted to critical care diagnosed with COVID-19 infection. DESIGN: Retrospective database study. SETTING: Data reported to the Virtual Pediatric Systems, 2018–2021. PATIENTS: Patients 28 days to younger than 18 years old, admitted to a PICU with either PE or COVID-19 diagnoses. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the PE-positive subgroups, from January 2020 to December 2021, 78 patients (14%) had an acute COVID-19 infection. The prevalence of PE pre-pandemic period (2018–2019) was 0.19% and for pandemic period (2020–2021) was 0.26% (p < 0.001). During the pandemic period, the prevalence of PE for COVID-negative patients was 0.21% and for COVID-positive patients was 1.01% (p < 0.001). The result shows that the chance to develop PE for COVID-positive patients is 4.8 times that for COVID-negative patients during the pandemic. In the subgroup of the PE-positive patients, 55.1% were Black or African American in the COVID-positive group and 19% in the COVID-negative group (p < 0.001). A multivariable logistic regression showed that race was an independent risk factor for COVID in PE-positive patients. CONCLUSIONS: Our study demonstrates a significant increase in the prevalence of PE among pediatric patients admitted to PICUs during the COVID-19 pandemic compared with pre-pandemic. Our study indicates that COVID-positive patients are 4.8 times more likely to develop PE than COVID-negative patients. Additionally, the study highlights substantial racial disparities in the prevalence of PE, with Black or African American patients being disproportionately affected.
- 15 January 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (1) , e1206
Open AccessPrevalence of Pulmonary Embolism in COVID-19 Positive Critically Ill Children
OBJECTIVES: To investigate the prevalence of pulmonary embolism (PE) in children admitted to critical care diagnosed with COVID-19 infection. DESIGN: Retrospective database study. SETTING: Data reported to the Virtual Pediatric Systems, 2018–2021. PATIENTS: Patients 28 days to younger than 18 years old, admitted to a PICU with either PE or COVID-19 diagnoses. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the PE-positive subgroups, from January 2020 to December 2021, 78 patients (14%) had an acute COVID-19 infection. The prevalence of PE pre-pandemic period (2018–2019) was 0.19% and for pandemic period (2020–2021) was 0.26% (p < 0.001). During the pandemic period, the prevalence of PE for COVID-negative patients was 0.21% and for COVID-positive patients was 1.01% (p < 0.001). The result shows that the chance to develop PE for COVID-positive patients is 4.8 times that for COVID-negative patients during the pandemic. In the subgroup of the PE-positive patients, 55.1% were Black or African American in the COVID-positive group and 19% in the COVID-negative group (p < 0.001). A multivariable logistic regression showed that race was an independent risk factor for COVID in PE-positive patients. CONCLUSIONS: Our study demonstrates a significant increase in the prevalence of PE among pediatric patients admitted to PICUs during the COVID-19 pandemic compared with pre-pandemic. Our study indicates that COVID-positive patients are 4.8 times more likely to develop PE than COVID-negative patients. Additionally, the study highlights substantial racial disparities in the prevalence of PE, with Black or African American patients being disproportionately affected.